We are excited. #camoco19

Most covid models are not forecasts in the way we forecast weather. Covid models inform policy and personal decisions that feed back into the model dynamics. When the models ‘overestimated’ it means they worked.

Patient number 25 enrolled in the weekend in our camostat trial #camoco19 #COVID19 #auhdk

Now that is just something

Patient number 40 now enrolled in our camostat trial #camoco19 #dkpol. Infektion rate currently low in DK.

Great effort!

Well done all involved and to the patients willing to be a part of this trial!

Our review on camostat mesylate is out. doi.org/10.1111/bcpt.1… at @ BasClinPharmTox. Thanks for support from #lundbeckfonden. #camoco19 #auhdk #aarhusuniversity

Med vores ambitiøse 2030-strategi melder vi klart ud, hvad vi ønsker at opnå og hvordan. Og vi får travlt! #dkfonde #dkbiz

Xkcd for the win. Univ. of Puget Sound ASM xkcd.com/2404

My first tweet of 2021 is going to be about 1 dose vs. 2 dose vaccine. I have tweeted in the past of the immunological advantages of a 2 dose vaccine. However, given the enhanced transmission variants on the rise, we need a modified strategy. (1/n) theatlantic.com/science/archiv…

Proud to be part of the research group showing effect of Camostat and the metabolite GBPA in cell system and lung organoids with Stefan Pohlmann and colleagues. thelancet.com/journals/ebiom…. #auhdk #aarhusUni #dandrite #covid19dk #stenoaarhus

Privatfinansieret forskning bliver ikke styret eller har skjulte hensigter. Vi skal ikke blande os i forskningen eller resultaterne – Det vil ødelægge den gode forskning og fondsmodel, vi har i Danmark. Det skriver jeg om i Altinget. #dkfonde #dkforsk altinget.dk/forskning/arti…

Correlation Vs. Causation

Well done!

#lundbeckfonden are proud sponsors of #dkbio dkbio.org. #sniprbiome, #nmd, #vesperbio will join an excellent line up of Danish biotech in #boston April 5-7.

lundbeckfonden.com/en/nyheder/lun… The new head of Lundbeckfonden BioCapital, Christian Elling: "We will focus on identifying and cultivating promising Danish start-ups which can develop into mature biotech companies with the potential to become important players within healthcare" #biotech

Big day! Our first clinical trial has begun - we are dosing humans with the CRISPR therapeutic, SNIPR001 - designed to selectively eradicate E. coli in the gut, preventing bacteremia in cancer patients. Thanks for the support CARB-X sniprbiome.com/news-press

Congratulations to the 7 winners and their collaborators and a huge thanks to everyone who took the time to apply for this grant programme. lundbeckfonden.com/en/news/the-lu…

Let’s meet in Dublin! The Lundbeckfonden BioCapital team will be attending #BIOEQUITY 2023 and are open to network and partnering. Reach out if you would like to meet with us: lundbeckfonden.com/business-activ… #biotech #lifescience #venturecapital #investors #partnering